AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

NORTHERN VENTURE TRUST PLC

Regulatory Filings Dec 5, 2025

4746_rns_2025-12-05_5222b03a-9c19-4527-9e58-a5bef50cec24.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Northern Venture Trust PLC

Half-Yearly Financial Report 30 September 2025

Contents

  • 01 Financial summary
  • 02 Half-yearly management report
  • 04 Investment policy
  • 05 Five-year performance
  • 06 Investment portfolio
  • 07 Statement of the Directors' responsibilities
  • 08 Income statement
  • 09 Balance sheet
  • 10 Statement of changes in equity
  • 11 Statement of cash flows
  • 12 Notes to the financial statements
  • 15 Company information

Welcome

Northern Venture Trust PLC is a Venture Capital Trust (VCT) advised by Mercia Fund Management Limited (the Investment Adviser).

The trust was one of the first VCTs launched on the London Stock Exchange, in 1995. It invests mainly in unquoted venture capital holdings and aims to provide long-term tax-free returns to shareholders through a combination of dividend yield and capital growth.

Financial summary

Unaudited
six months ended
30 September
2025
Unaudited
six months ended
30 September
2024
Audited
year ended
31 March
2025
Net assets £131.7m £119.3m £121.3m
Net asset value per share 60.7p 59.9p 61.5p
Return per share
Revenue 0.1p 0.2p 0.4p
Capital 0.7p 1.0p 3.8p
Total 0.8p 1.2p 4.2p
Dividend per share declared in respect of the period 1.6p 1.6p 3.1p
Cumulative return to shareholders since launch
Net asset value per share 60.7p 59.9p 61.5p
Dividends paid per share* 196.8p 193.7p 195.3p
Net asset value plus dividends paid per share 257.5p 253.6p 256.8p
Mid-market share price at end of period 56.50p 56.0p 57.00p
Share price discount to net asset value 6.9% 5.7% 7.3%
Annualised tax-free dividend yield (based on the net asset value per
share)**
5.2% 5.2% 5.1%

* Excluding interim dividend not yet paid.

Key dates

20 November 2025

Half-yearly results announced

18 December 2025

Shares quoted ex dividend

21 January 2026

Interim dividend paid (to shareholders on register on 19 December 2025)

** The dividend yield is calculated by dividing the dividends declared in the 12 month period ended on each reference date by the net asset value per share at the start of that period.

Deborah Hudson Chair

We are pleased to report a net increase in the holding value of the unquoted portfolio."

Half-yearly management report

for the six months ended 30 September 2025

It is my pleasure to present our half-yearly financial report. Despite UK economic headwinds, Northern Venture Trust has made gratifying progress. UK economic conditions from April to September remained challenging, with modest growth, inflation still above the Bank of England's target and higher gilt yields, which appear to reflect market concern about the UK's publicfinances ahead of a fiscally challenging Autumn Budget. Against this backdrop, the portfolio has continued to perform well. The Company has maintained its long-term strategy of investing in promising early-stage businesses, supporting its existing portfolio companies, and generating cash from realisations where circumstances permit.

Venture capital investment activity and portfolio update

We are pleased to report a net increase in the holding value of the unquoted portfolio. Strong performances from a number of portfolio companies have uplifted valuations, outweighing the reductions made to valuations of companies that have performed less well.

During the period, we made a new investment totalling £2.3 million in Thanks Ben, an employee benefits orchestration platform. We have also invested £3.1 million in ten existing portfolio companies. In the period since 30 September 2025, £4.0 million has been invested into seven companies, including a new investment into Space and Time Limited (t/a Tesseract).

During the period, partial realisations were made in Buoyant Upholstery and Fresh Approach at our 31 March 2025 holding value, and in Angle plc, a listed investment, at a price marginally below year-end holding value.

One further realisation has also successfully completed, with Thanksbox Limited (t/a Mo) returning £0.9 million, a £0.5 million uplift on June's holding value.

We were also pleased to announce that shortly after the period end, portfolio company Project Glow (trading as The Beauty Tech Group) successfully completed its IPO on the London Stock Exchange. This was picked up by multiple press outlets as an encouraging sign of activity returning to the UK stock market, and is a very positive step for the company, which the Northern VCTs have supported since 2018. As part of the transaction, the Company realised 30% of its holding, generating cash proceeds of £2.5 million and delivering a 5.8x return on our original investment cost.

Results and dividend

The total return per share before dividends for the six months ended 30 September 2025 as shown in the income statement was 0.8 pence, compared with 1.2 pence in the corresponding period last year. The performance was driven by an unrealised increase of £2.4 million in the valuation of investments.

Six years ago, we introduced a target dividend yield of 5% of opening NAV, which has been exceeded in each of the years since then. On 5 September 2025 the final dividend of 1.5 pence in respect of the period ending 31 March 2025 was paid to shareholders. After careful consideration, and taking our target yield into account, we have decided to declare an interim dividend of 1.6 pence per share in respect of the year to 31 March 2026. The interim dividend will be paid on 21 January 2026 to shareholders on the register on 19 December 2025. Taking account of this interim dividend, the unaudited net asset value (NAV) per share at 30 September 2025 was 60.7 pence (61.5 pence (audited) on 31 March 2025).

We continue to operate our dividend investment scheme, which enables shareholders to invest their dividends in new ordinary shares free of dealing costs and with the benefit of the tax reliefs available on new VCT share subscriptions. We have included details of the scheme within the dividend section of our website, which can be found at: www.mercia.co.uk/vcts/nvt/.

Shareholder matters

As a result of the fully subscribed public share offer launched in January 2025, 24,216,029 shares were issued for gross proceeds of £15.0 million.

We continue to observe a sustained demand for long-term growth capital for smaller companies in the UK. In order to continue to support our existing portfolio and invest in new early-stage opportunities, we are currently fundraising in conjunction with the other Northern VCTs. Full details of how to participate in the fundraise are available on the Company's website at www.mercia.co.uk/vcts .

We have maintained our policy of being willing to buy back the Company's shares in the market to maintain liquidity, at a 5% discount to NAV. During the period a total of 5,321,117 shares were purchased by the Company for cancellation, representing around 2.7% of the opening ordinary share capital.

VCT legislation and qualifying status

The Company has continued to meet the stringent and complex qualifying conditions laid down by HM Revenue & Customs for maintaining its approval as a VCT. The Investment Adviser monitors the position closely and reports regularly to the Board. Philip Hare & Associates LLP has continued to act as independent adviser to the Company on VCT taxation matters.

Board composition

We have previously reported the retirement from the Board of director David Mayes. We would like to reiterate our gratitude to David for his years of dedicated service and significant contributions to the Company.

We are confident the Company remains in capable hands. The Board's collective experience and commitment will ensure we continue to act in the best interests of our shareholders.

Outlook

Despite ongoing macroeconomic headwinds, the portfolio continues to demonstrate resilience and growth potential. We remain confident in the strength and quality of the underlying companies, many of which are well positioned to benefit from long-term economic and technological trends. The Company will continue to invest selectively through the cycle, supporting high-growth businesses with strong fundamentals, while also seeking to deliver timely realisations where opportunities arise. With a diversified portfolio and a clear strategy for growth, we believe the Company is well placed to continue to create shareholder value in the years ahead.

On behalf of the Board

Deborah Hudson

Chair

Investment policy

The Company's investment policy has been designed to enable the Company to achieve its objective whilst complying with the qualifying conditions set out in the VCT rules, as amended by HM Government from time to time.

The Directors intend that the long-term disposition of the Company's assets will be approximately 80% in a portfolio of VCT-qualifying unquoted and AIM-quoted investments, and 20% in other investments selected with a view to producing an enhanced return while avoiding undue capital volatility, to provide a reserve of liquidity which will maximise the Company's flexibility as to the timing of investment acquisitions and disposals, dividend payments and share buy-backs.

Within the VCT-qualifying portfolio, investments will be structured using various investment instruments, including ordinary and preference shares, loan stocks and convertible securities, to achieve an appropriate balance of income and capital growth. The selection of new investments will necessarily have regard to the VCT rules, which are designed to focus investment on earlier stage development capital opportunities. The portfolio will be diversified by investing in a broad range of VCT-qualifying industry sectors and by holding investments in companies at different stages of maturity in the corporate development cycle. The normal investment holding period is expected to be in the range from three to ten years.

No single investment will normally represent in excess of 3% of the Company's total assets at the time of initial investment. As investments are held with a view to long-term capital growth as well as income, it is possible that individual holdings may grow in value to the point where they represent a significantly higher proportion of total assets prior to a realisation opportunity being available.

Investments will normally be made using the Company's equity shareholders' funds and it is not intended that the Company will take on any long-term borrowings.

The Company operates within a co-investment and allocation policy that applies to all funds managed by the Mercia group. Under the terms of this policy, where an investment opportunity is VCT qualifying and the funding requirement is in excess of £3 million, the Company and the other VCTs managed by Mercia are the preferred lead investors. For these opportunities the Company is entitled to participate pro rata to net assets alongside the other VCT funds managed by Mercia; save where the investment opportunity is located in the West or East Midlands, Yorkshire, Humberside, Teesside or the North East, where minimum syndication requirements mean that certain other funds managed by Mercia can participate in the funding round alongside the Northern VCTs; with an allocation in proportion to each fund's relative net asset value. Where the funding round for a new opportunity is under £3 million the VCTs will not be the lead investors; but if any such deal is in excess of £2.5 million, the Northern VCT funds have the right to participate at a de minimis level of £0.5 million.

In relation to follow-on rounds of investment where the Company and other Northern VCTs are existing investors, the Company, alongside the other Northern VCT funds, shall have priority to determine how much they wish to invest, with no requirement to offer such investment opportunities to the other funds managed or advised by the Mercia group.

Under a co-investment scheme, members of the VCT investment team and certain key Mercia executives are required to invest personally alongside the funds in each VCT-qualifying investment on a predetermined basis.

Mercia Fund Management Limited (Mercia) acts as the Investment Adviser and has done so since the Company consented to the novation of its existing investment advisory agreement from NVM Private Equity LLP (NVM) effective on 23 December 2019.

The Board's Management Engagement Committee reviews the terms of Mercia's appointment as Investment Adviser on a regular basis.

Five-year performance

Comparative return to shareholders (assuming dividends re-invested)

Five years to 30 September 2025 (30 September 2020 = 100)

  • Northern Venture Trust NAV total return
  • Northern Venture Trust share price total return
  • FTSE All-Share Index total return

Net asset value and cumulative dividends per share

As at 30 September (pence per share)

  • Net asset value per share
  • Cumulative dividends paid

Investment portfolio

As at 30 September 2025 (unaudited)

Fifteen largest venture capital investments Description Cost
£000
Valuation
£000
% of net assets
by value
Project Glow Topco (t/a The Beauty Tech Group) Online marketplace for home-use beauty products 1,444 8,169 6.2%
Pure Pet Food Production of organic pet food 1,675 6,910 5.2%
Pimberly Product information management software 2,060 3,604 2.7%
Rockar E-commerce and fulfilment platform for new car sales 1,877 3,500 2.7%
Tutora (t/a Tutorful) Website to help parents and students find private tutors 3,305 3,305 2.5%
Forensic Analytics Call data communications analytics software 2,717 2,717 2.1%
Netacea AI-powered cyber security consultancy 2,631 2,631 2.0%
Ridge Pharma Sale of pharmaceuticals (branded, generics, specials) 1,497 2,573 2.0%
Biological Preparations Group Environmental biotechnology products 2,366 2,548 1.9%
Broker Insights Platform connecting insurers and brokers 2,416 2,541 1.9%
Administrate SAAS training management and LMS platform 3,444 2,468 1.9%
Risk Ledger Cyber security focused on supply chain risk 1,412 2,461 1.9%
Semble Practice management software for healthcare clinicians/clinics 1,951 2,433 1.9%
Send Technology Solutions Platform for insurers, reinsurers, and managing general agents 1,949 2,284 1.7%
Thanks Ben Employee benefits orchestration platform 2,280 2,280 1.7%
Fifteen largest venture capital investments 33,024 50,424 38.3%
Other venture capital investments 58,556 50,401 38.3%
Total venture capital investments 91,580 100,825 76.6%
Net current assets 30,879 23.4%
Net assets 131,704 100.0%

Statement of the Directors' responsibilities

Responsibility statement

In accordance with Disclosure and Transparency Rule (DTR) 4.2.10, Deborah Hudson (Chair), Brigid Sutcliffe (Chair of the Audit Committee) and John E Milad, being the Directors of the Company, confirm that to the best of their knowledge:

  • (a) The condensed set of financial statements, which has been prepared in accordance with Financial Reporting Standard 104 "Interim Financial Reporting" gives a true and fair view of the assets, liabilities, financial position and profit of the Company as required by DTR 4.2.10;
  • (b) the half-yearly management report includes a fair review of the information required by DTR 4.2.7, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;
  • (c) a description of the principal risks and uncertainties facing the Company for the remaining six months of the financial year are set out under the summary of principal risks and uncertainties below, in accordance with DTR 4.2.7; and
  • (d) there were no related party transactions in the first six months of the current financial year that are required to be disclosed, in accordance with DTR 4.2.8.

Principal risks and uncertainties

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Financial Statements for the year ended 31 March 2025 ("the Annual Report"). The Board considers that the present processes for mitigating those risks remain appropriate. Following the admission of the Company's largest investment on the London Stock Exchange in October 2025, the Board has included stock market risk as an additional principal risk to those included in the Annual Report. Stock market risk is the risk of adverse price

movements on the Company's listed portfolio holdings as a result of macroeconomic or other factors resulting in the decline of the overall market.

The principal risks faced by the Company are:

  • Availability of qualifying investments risk
  • Credit risk
  • Economic and geopolitical risk
  • Financial risk
  • Investment and liquidity risk
  • Legislative and regulatory risk
  • Operational risk
  • Performance of the Investment Adviser risk
  • Stock market risk
  • VCT qualifying status risk

A detailed explanation of the principal risks facing the Company can be found in the Annual Report and Financial Statements for the year ended 31 March 2025 on pages 21 to 22, as well as in Note 18 on Financial Instruments on pages 68 to 71 of that report. Copies can be viewed or downloaded from the Company's website: www.mercia.co.uk/vcts.

Environmental, Social and Governance considerations

The Company is committed to conducting its affairs responsibly and considers environmental, social and governance (ESG) issues as part of its operations. More details of the Company's considerations can be found in the Responsible Investment section in the Annual Report and Financial Statements for the year ended 31 March 2025 on pages 33 to 34.

Going concern

The Board has assessed the Company's operation as a going concern. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out earlier in the half-yearly management report. The Directors have satisfied themselves that the Company's cash position is adequate to enable the Company to continue as a going concern under downside scenarios. The portfolio remains well funded and the Advisers' investment team are ensuring that management teams undertake adequate cost control and cashflow planning. The major cash outflows of the Company (namely investments, share buy-backs and dividends) are within the Company's control. The Board's assessment of liquidity risk and details of the Company's policies for managing its capital and financial risks are shown in Note 18 of the Annual Report and Financial Statements for the year ended 31 March 2025 on pages 68 to 71. Accordingly, the Directors continue to adopt the going concern basis of accounting in preparing the half-yearly report and financial statements.

Cautionary statement

This report may contain forward looking statements with regard to the financial condition and results of the Company, which are made in the light of current economic and business circumstances. Nothing in this report should be construed as a profit forecast.

For and on behalf of the Board:

Deborah Hudson Chair

20 November 2025

Condensed income statement

For the six months ended 30 September 2025

Unaudited six months ended
30 September 2025
Unaudited six months ended
30 September 2024
Audited year ended
31 March 2025
Notes Revenue
£000
Capital
£000
Total
£000
Revenue
£000
Capital
£000
Total
£000
Revenue
£000
Capital
£000
Total
£000
Gain/(loss) on disposal of investments (2) (2) 1,705 1,705 3,555 3,555
Movements in fair value of investments 2,413 2,413 954 954 5,603 5,603
2,411 2,411 2,659 2,659 9,158 9,158
Dividend and interest income
3
933 933 1,020 1,020 2,594 2,594
Investment management fee
4
(305) (915) (1,220) (280) (841) (1,121) (568) (2,103) (2,671)
Other expenses (289) (289) (320) (320) (600) (600)
Return before tax 339 1,496 1,835 420 1,818 2,238 1,426 7,055 8,481
Tax on return (50) 50 (101) 101 (592) 592
6
Return after tax
289 1,546 1,835 319 1,919 2,238 834 7,647 8,481
Return per share 0.1p 0.7p 0.8p 0.2p 1.0p 1.2p 0.4p 3.8p 4.2p

The total column of the income statement is the statement of total comprehensive income of the Company prepared in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". The supplemental revenue return and capital return columns have been prepared in accordance with the Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued in July 2022 by the Association of Investment Companies ("AIC SORP").

  • There are no recognised gains or losses other than those disclosed in the income statement.
  • All items in the above statement derive from continuing operations.
  • The accompanying notes are an integral part of this statement.

Condensed balance sheet

As at 30 September 2025

Notes Unaudited
30 September
2025
£000
Unaudited
30 September
2024
£000
Audited
31 March
2025
£000
Fixed assets
Investments 100,825 84,185 93,537
Current assets
Debtors 118 559 2,895
Cash and cash equivalents 30,949 34,727 25,439
31,067 35,286 28,334
Creditors (amounts falling due within one year) (188) (167) (620)
Net current assets 30,879 35,119 27,714
Net assets 131,704 119,304 121,251
Capital and reserves
Called-up equity share capital 54,232 49,790 49,302
Share premium 44,073 35,077 35,348
Capital redemption reserve 9,806 7,769 8,476
Capital reserve 13,601 26,805 20,451
Revaluation reserve 9,244 (913) 6,779
Revenue reserve 748 776 895
Total equity shareholders' funds 131,704 119,304 121,251
Net asset value per share
7
60.7p 59.9p 61.5p

Condensed statement of changes in equity

Non-distributable reserves Distributable reserves
Six months ended 30 September 2025 (unaudited) Called-up
share capital
£000
Share
premium
£000
Capital
redemption
reserve
£000
Revaluation
reserve*
£000
Capital
reserve
£000
Revenue
reserve
£000
Total
£000
At 1 April 2025 49,302 35,348 8,476 6,779 20,451 895 121,251
Return after tax 2,465 (919) 289 1,835
Dividends paid (2,835) (436) (3,271)
Net proceeds of share issues 6,260 8,725 14,985
Shares purchased for cancellation (1,330) 1,330 (3,096) (3,096)
At 30 September 2025 54,232 44,073 9,806 9,244 13,601 748 131,704
Six months ended 30 September 2024 (unaudited)
At 1 April 2024 47,615 30,418 6,658 882 28,099 1,159 114,831
Return after tax (1,795) 3,714 319 2,238
Dividends paid (2,508) (702) (3,210)
Net proceeds of share issues 3,286 4,659 7,945
Shares purchased for cancellation (1,111) 1,111 (2,500) (2,500)
At 30 September 2024 49,790 35,077 7,769 (913) 26,805 776 119,304
Year ended 31 March 2025**
At 1 April 2024 47,615 30,418 6,658 882 28,099 1,159 114,831
Return after tax 5,897 1,750 834 8,481
Dividends paid (5,282) (1,098) (6,380)
Net proceeds of share issues 3,505 4,930 8,435
Shares purchased for cancellation (1,818) 1,818 (4,116) (4,116)
At 31 March 2025 49,302 35,348 8,476 6,779 20,451 895 121,251

* The revaluation reserve is generally non-distributable other than that part of the reserve relating to gains/losses on readily realisable quoted investments, which are distributable.

** Comparative figures have been extracted from the audited statutory accounts for the year ended 31 March 2025.

Condensed statement of cash flows

For the six months ended 30 September 2025

Unaudited
six months ended
30 September
2025
£000
Unaudited
six months ended
30 September
2024
£000
Audited
year ended
31 March
2025
£000
Cash flows from operating activities
Return before tax 1,835 2,238 8,481
Adjustments for:
(Gain)/loss on disposal of investments 2 (1,705) (3,555)
Movements in fair value of investments (2,413) (954) (5,603)
Decrease in debtors 2,777 392 58
(Decrease)/increase in creditors (432) (24) 429
Net cash inflow/(outflow) from operating activities 1,769 (53) (190)
Cash flows from investing activities
Purchase of investments (5,393) (5,936) (14,258)
Sale/repayment of investments 516 6,984 10,451
Net cash inflow/(outflow) from investing activities (4,877) 1,048 (3,807)
Cash flows from financing activities
Issue of ordinary shares 15,474 8,290 8,801
Share issue expenses (489) (345) (366)
Purchase of ordinary shares for cancellation (3,096) (2,500) (4,116)
Equity dividends paid (3,271) (3,210) (6,380)
Net cash inflow/(outflow) from financing activities 8,618 2,235 (2,061)
Net increase/(decrease) in cash and cash equivalents 5,510 3,230 (6,058)
Cash and cash equivalents at beginning of period 25,439 31,497 31,497
Cash and cash equivalents at end of period 30,949 34,727 25,439

Notes to the condensed financial statements

For the six months ended 30 September 2025 (unaudited)

1. Basis of Preparation

These financial statements are prepared in accordance with accounting policies consistent with Financial Reporting Standard 102 ("FRS102"), Financial Reporting Standard 104 ("FRS104") - Interim Financial Reporting, with the Companies Act 2006 and the 2014 Statement of Recommended practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ("the SORP") (updated in July 2022) issued by the Association of Investment Companies ("AIC"). These condensed financial statements comply with FRS 104, applying the recognition and measurement principles of FRS 102. The financial statements have been prepared on a going concern basis.

The preparation of the financial statements requires management to make judgements and estimates that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The most critical estimates and judgements relate to the determination of carrying value of investments at fair value through profit and loss ("FVTPL") in accordance with FRS 102 sections 11 and 12. The Company values investments by following the International Private Equity and Venture Capital Valuation ("IPEV") Guidelines as updated in 2022 and further detail on the valuation techniques used are outlined in note 2 below.

2. Accounting Policies

The accounting policies have been applied consistently throughout the period. Full details of principal accounting policies are disclosed in Note 1 on page 57 of the Annual Report and Financial Statements for the year ended 31 March 2025. The significant accounting estimates and judgements applied are consistent with those disclosed in the Annual Report for the year ended 31 March 2025.

3. Income

Unaudited
six months ended
30 September 2025
£000
Unaudited
six months ended
30 September 2024
£000
Audited
year ended
31 March 2025
£000
Dividends income 141 17 21
Money market funds 618 588 1,110
Bank deposits 132 224 347
Interest income from loans to unquoted companies 42 191 1,116
933 1,020 2,594

4. Investment management fee

Unaudited
six months ended
30 September 2025
£000
Unaudited
six months ended
30 September 2024
£000
Audited
year ended
31 March 2025
£000
Investment management fee charged to capital 915 841 1,704
Investment management fee charged to revenue 305 280 568
Performance-related fee charged to capital 399
1,220 1,121 2,671

Further details of the agreement under which the investment management fee and performance-related fee are paid are given in the Directors' Report on page 37 and in Note 3 on page 60 of the Annual Report and Financial Statements for the year ended 31 March 2025.

5. Dividends

Unaudited
six months ended
30 September 2025
£000
Unaudited
six months ended
30 September 2024
£000
Audited
year ended
31 March 2025
£000
Final dividend paid – 1.5p (2024: 1.6p) per share 3,271 3,210 3,210
Interim dividend paid – 1.6p (2024: 1.6p) per share 3,170
3,271 3,210 6,380

The interim dividend of 1.6 pence per share for the year ending 31 March 2026 will be paid on 21 January 2026 to shareholders on the register on 19 December 2025.

6. Return per share

The calculation of the return per share is based on the return after tax for the six months ended 30 September 2025 and on 219,187,995 (30 September 2024: 201,421,491) ordinary shares, being the weighted average number of shares in issue during the period.

Notes to the condensed financial statements continued

7. Net asset value per share

The calculation of net asset value per share is based on the net assets at 30 September 2025 divided by the 216,925,150 (30 September 2024: 199,158,435) ordinary shares in issue at that date.

8. Related party transactions

Other than transactions with the Investment Adviser as disclosed in note 4, there are no other related party transactions requiring disclosure.

9. Going concern

The financial statements have been prepared on a going concern basis. The Directors performed an assessment of the Company's ability to meet its liabilities as they fall due. In performing this assessment, the Directors took into consideration the uncertain economic outlook including:

  • the investments and liquid resources held by the Company;
  • the fact that the Company has no debt or capital commitments;
  • the ability of the Company to meet all of its liabilities and ongoing expenses from its assets, including its period-end cash balance;
  • revenue and operating cost forecasts for the forthcoming year;
  • the ability of third-party service providers to continue to provide services; and
  • potential downside scenarios including a fall in the valuation of the investment portfolio or levels of investment income.

Based on this assessment, the Directors are confident that the Company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements, and therefore determine the going concern basis to be appropriate. Details of the significant post-balance sheet events are given in Note 10 of the financial statements.

10.Post balance sheet events

On 3 October 2025, portfolio company The Beauty Tech Group completed its IPO on the London Stock Exchange. As part of this transaction the Company sold 30% of its holding for proceeds of £2.5 million.

On 22 October 2025 the Company invested £1,336,000 in a new portfolio company, Space and Time Limited (trading as Tesseract). Tesseract is a provider of field service management software.

On 30 October 2025, the investment in Thanksbox (trading as Mo) was sold for £906,000.

Since the balance sheet date, the Company has invested £2,713,000 in six existing portfolio companies.

11.Other information

The information set out in this half-yearly financial report does not constitute the Company's statutory accounts within the terms of section 434 of the Companies Act 2006 for the periods ended 30 September 2025 and 30 September 2024 and is unaudited. The financial information for the year ended 31 March 2025 does not constitute statutory accounts within the terms of section 434 of the Companies Act 2006 and is derived from the statutory accounts for that financial year, which have been delivered to the Registrar of Companies. The Auditor reported on those accounts; their report was unqualified and did not contain a statement under s498 (2) or (3) of the Companies Act 2006.

12.Publication

This half-yearly financial report is being sent to shareholders and copies will be made available to the public at the registered office of the Company, Companies House, the National Storage Mechanism and also electronically at www.mercia.co.uk/vcts.

Company information

Company Number

03090163

ISIN

GB0006450703

Directors

Deborah Hudson (Chair) John Milad Brigid Sutcliffe

Secretary

Mercia Company Secretarial Services Limited

Registered office

Forward House 17 High Street Henley-in-Arden B95 5AA

Investment adviser

Mercia Fund Management Limited Forward House 17 High Street Henley-in-Arden B95 5AA

Registrar

The City Partnership (UK) Limited The Mending Rooms Park Valley Mills Meltham Road Huddersfield HD4 7BH

01484 240 910 [email protected]

Corporate Broker

Panmure Liberum Limited Ropemaker Place Level 12 25 Ropemaker Street London EC2Y 9LY

Northern Venture Trust PLC

Forward House 17 High Street Henley-in-Arden B95 5AA

www.mercia.co.uk/vcts/nvt/

Talk to a Data Expert

Have a question? We'll get back to you promptly.